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Abstract
Objective: The goal of this contribution is to gather and to critically analyze recent evidence regarding the
potential of exergaming for Parkinson’s disease (PD) rehabilitation and to provide an up-to-date analysis of the
current state of studies on exergame-based therapy in PD patients.
Methods: We performed our search based on the conclusions of a previous systematic review published in 2014.
Inclusion criteria were articles published in the indexed databases Pubmed, Scopus, Sciencedirect, IEEE and Cochrane
published since January 1, 2014. Exclusion criteria were papers with a target group other than PD patients exclusively,
or contributions not based on exergames. Sixty-four publications out of 525 matches were selected.
Results: The analysis of the 64 selected publications confirmed the putative improvement in motor skills suggested by
the results of the previous review. The reliability and safety of both Microsoft Kinect and Wii Balance Board in the
proposed scenarios was further confirmed by several recent studies. Clinical trials present better (n = 5) or similar (n = 3)
results than control groups (traditional rehabilitation or regular exercise) in motor (TUG, BBS) and cognitive (attention,
alertness, working memory, executive function), thus emphasizing the potential of exergames in PD. Pilot studies (n =
11) stated the safety and feasibility of both Microsoft Kinect and Wii Balance Board, potentially in home scenarios as
well. Technical papers (n = 30) stated the reliability of balance and gait data captured by both devices. Related meta-
analyses and systematic reviews (n = 15) further support these statements, generally citing the need for adaptation to
patient’s skills and new input devices and sensors as identified gaps.
Conclusion: Recent evidence indicates exergame-based therapy has been widely proven to be feasible, safe, and at
least as effective as traditional PD rehabilitation. Further insight into new sensors, best practices and different cognitive
stadiums of PD (such as PD with Mild Cognitive Impairment), as well as task specificity, are required. Also, studies
linking game parameters and results with traditional assessment methods, such as UPDRS scores, are required.
Outcomes for randomized controlled trials (RCTs) should be standardized, and follow-up studies are required,
particularly for motor outcomes.
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Introduction
Parkinson’s Disease (PD) is caused by the progressive de-
generation of dopaminergic neurons in the substantia
nigra pars compacta, reduced striatal dopamine, and the
presence of Lewy Bodies. Its most common form, Idio-
pathic Parkinson’s Disease, is determined by cardinal
symptoms: Rest tremor, asymmetry, bradykinesia and a
good response to dopamine confirm the pathology in
99% of cases.
Besides motor symptoms, cognitive dysfunctions occur
very often in PD Patients [1, 2]. Once cognitive impair-
ment can be objectified in PD patients, it is called Mild
Cognitive Impairment in PD (PD-MCI). Criteria for a
diagnosis of PD-MCI following the Petersen criteria in-
cludes a gradual decline in cognitive ability in the context
of PD, cognitive deficits on a formal neuropsychological
test and a cognitive deficit which is not sufficient to inter-
fere with functional independence, but presenting subtle
difficulties on complex functional tasks [3]. The preva-
lence of PD-MCI among PD patients is around 25% [4].
Furthermore, PD-MCI is a risk factor for a further cogni-
tive decline into PD Dementia (PDD), which is character-
ized by cognitive symptoms in at least two domains (e.g.
memory, executive function) which cause dysfunction in
activities of daily living (ADL). PDD is an exclusion criter-
ion for some PD treatments [5] such as Deep Brain Stimu-
lation, and there is no strategy to prevent cognitive
decline in PD patients or approved pharmacological ap-
proach to treat PD-MCI at the moment [5]. However,
recent research suggests that cognitive function can be
improved, or stabilized, in patients with PD through cog-
nitive training [6–8]. Although at this point the ideal type
or intervention frequency of cognitive training therapy for
PD patients with either PD-MCI or initial PDD is not
clear, several clinical studies indicate cognitive training im-
proves executive and memory functions in PD patients.
Meta-analyses also stress the need to provide clear inclu-
sion and exclusion criteria in interventions for cognitive
training and PD, considering the three stages of cognitive
decline in PD [9]. It is also discussed that a combined
treatment of cognitive and physical training seems to be a
good option [10, 11]. Additional advantages of this strat-
egy are transfer effects between cognitive and motor skills,
for example, the positive effects of cognitive training in
physical symptoms such as freezing of gait [12].
It is precisely due to the potential transfer effects that
exergames [13] show great potential for PD rehabilita-
tion since one of the best methods to combine both cog-
nitive and physical training is the use of video games
which require the user to perform physical movements
while conducting cognitive exercises. Exergames, a port-
manteau of exercise and games, aim to combine the mo-
tivational aspects of playing with the physical benefits of
exercise. In regard to target groups and activities, such
as exergames for rehabilitation, adapting to the particu-
lar needs of the users, and to their physical and cognitive
capabilities, are usually mentioned as significant advan-
tages over alternative rehabilitation methods [14].
Additionally, the confirmed reliability of sensory feed-
back from traditional exergaming platforms such as the
Wii Balance Board (WBB) or Microsoft Kinect is backed
by numerous publications from recent years [15–33].
On the specific topic of exergames for PD rehabilita-
tion, a systematic review published in 2014 by Barry et
al. [34] found a total of 1121 abstracts related, to some
degree, to the use of exergames in PD. Seven clinical
studies out of those publications were selected and ana-
lyzed. Their conclusions showed both, the promising fu-
ture of exergame-based PD therapy, as well as the lack
of rigorous clinical studies to evaluate its effectiveness.
Research in this area in recent years has been extensive,
but to this point, recent meta-analyses do not cover the
advance in the specific research area of exergame-based
PD rehabilitation. The goal of the present systematic re-
view is thus to study the progress of this area during the
years 2014 to 2017, with its focus set on sensors and
controllers, specifically comparing sensors based on
RCT outcomes where possible, as well as proposing the
use of additional sensors where available, thus providing
an up-to-date critical view of the work performed so far,
and identifying the remaining steps required until
exergame-based therapy may become a clinical standard
for PD patients.
Methods
In order to update the previous systematic review [34],
which covered publications until December 2013, we ini-
tially searched for publications using Barry et al’s previ-
ous searchline:
Exergam* OR active video gaming OR Microsoft Kinect
OR Kinect OR Nintendo Wii OR Wii OR Sony EyeToy
OR IREX OR Dance Dance Revolution AND
Parkinson*.
However, we found that Barry’s searchline excluded
significant research, and we thus updated the query „ac-
tive video gaming “ to the more comprehensive „video
gam* “ instead. We also removed duplicates, with a final
result of:
Exergam* OR Video Gam* OR Kinect OR Wii OR Sony
EyeToy OR IREX OR Dance Dance Revolution AND
Parkinson*.
Inclusion criteria were articles published in the
indexed databases Pubmed, Scopus, Sciencedirect, the
Institute of Electrical and Electronics Engineers (IEEE)
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and Cochrane published since January 1, 2014. Publica-
tions were not included for duplicates or if the topic did
not relate to this review despite a string match, that is, if
(A) the target group was not PD patients exclusively, or
(B) the employed therapy was not based on exergames.
Given the variety of outcomes of publications regarding
exergame therapy for PD, and considering most studies
provide two or three outcomes, we limited our analysis
to the main three outcomes given in case more than
three were provided. In case we had to limit the out-
comes of a study, standard ones were chosen where pos-
sible. The search was performed on February 26, 2018,
and again on November 27, 2018. The methods are pre-
sented in the flow diagram shown in Fig. 1. This yielded
the following results, excluding the aforementioned sys-
tematic review and the randomized clinical trials (RCT)
identified in it, which were nevertheless also included in
our analysis:
 Pubmed: 87 matches, of which we excluded 36
papers, leaving us with 51 results.
 Scopus: 163 matches, 8 Additional non-duplicate
publications using the same criteria.
 Sciencedirect: 249 matches, 5 Additional non-
duplicate publications using the same criteria.
 IEEE: 25 matches, 0 further results.
 Cochrane Library: 1 match, 0 further results.
From the 109 non-duplicate excluded papers, 77 were
excluded due to criterion A and 32 due to criterion B.
This reduced our corpus to a total of 64 publications,
which we then proceeded to classify into the following
groups:
 Group 1. RCTs of game- or game-technology based
methods in PD therapy. These are the primary focus
of this paper.
 Group 2. Pilot studies of game- or game-technology
based methods in PD therapy (non-RCTs). These
are the secondary focus of this paper.
 Group 3. Technical papers, with no specific
therapeutic focus (for example reliability tests). The
goal here is to provide an overview on recent
technical advances in the sector. This is summarized
in the discussion section.
 Group 4. Systematic reviews and meta-analyses re-
lating to the topic. The contents and goals of these
reviews are summarized in the discussion section.
In order for a study to qualify as an RCT, we used
the question and scoring criteria presented in Barry
et al’s systematic review [34], in which a study has
RCT consideration if satisfactorily answers the follow-
ing questions:
 Is inclusion and exclusion criteria stated?
 Are participant characteristics described in detail?
(number, age, sex, disease severity)
 Is sample size justified?
 Is group randomization explained?
 Is the design clear?
 Were exergaming sessions explained in detail?
 Were baseline and post-test data collected?
We also designated a publication as an RCT if all of these
questions were satisfactorily answered. We also decided to
include the previously existing RCT [35], for comparison.
Results
As a first step, we studied the input devices used on
each publication in groups 1 to 3. The results are pre-
sented in Table 1, while technical data about the sensors
mentioned in this publication is presented in Table 7.
We noticed there is a strong focus on using the Micro-
soft Kinect for PD rehabilitation (36 of 49 publications
used the Kinect) in comparison with other approaches,
such as the WBB, custom sensors or, in two cases, a Wii
hand controller (WiiMote). RCTs seem to focus on the
Kinect as well (3 out of 8 studies).
Group 1: RCTs (8)
Group 2: Pilot 
Studies (11)
Group 3: Technical 
papers (30)
Group 4: Metastudies
(15)
Pubmed: 87
Scopus: 163
Sciencedirect: 249
IEEE: 25
Cochrane: 1
Publications from 
Databases: n=525
Query: 
Exergam* OR 
Video Gam* 
OR Kinect OR 
Wii OR Sony 
EyeToy OR 
IREX OR 
Dance Dance 
Revolution 
AND 
Parkinson*
Selected 
publications: n=64
Duplicates: n=416
Excluded: n=109
Fig. 1 Flow Diagram of the study selection process
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Randomized Clinical Trials (RCTs)
The quality of studies in the area has drastically im-
proved in the last 4 years, and 8 new RCTs analyzing the
use of exergames in PD rehabilitation were identified in
this review [36–43]. Therefore, from this point onwards
we refer to a total of 9 RCTs including the one identified
in the previous review. A comprehensive list of the iden-
tified RCTs is presented in Additional file 1.
Given the variety of outcomes of these works, we limited
this section to the main three outcomes. Standard out-
comes, such as UPDRS Scores, MOCA Scores or standard
tests (Berg Balance Scale (BBS), Timed Up and Go Test
(TUG) were chosen where possible. Information about the
cognitive and motor dysfunctions of the control and inter-
vention groups can be extrapolated from pre-test UPDRS
and MMSE scores, which are provided where available. Ta-
bles 2 and 3 present a summary of all RCTs, particularly
participants, aim, duration and type of exergame, condition
trained and methods, settings, outcomes, and conclusions.
Table 4 compares RCT outcomes where possible. All stud-
ies had active control groups, and present results equal or
better than this control groups (which performed trad-
itional rehabilitation therapy or regular exercise), although
at this point it is still difficult to determine which therapy
works best. We consider the results of Allen et al. [36], and
Song et al. [41] to be of particular interest since the out-
comes of the intervention and control groups were similar
although the evaluation was performed at home in a min-
imally supervised scenario. Both authors insist on the need
to consider task specificity in the future.
We still observe several deficiencies in more recent
RCTs, namely the lack of standardized outcomes,
follow-up protocols and patient assessment methods,
which are further described in the discussion of this
paper. Regarding the risk of bias, seven of the clinical
trials are single-blinded and thus at risk of selection bias
[35, 37, 38, 40–43]. Out of these studies, three specific-
ally mention this risk. [37, 40, 43]. Only [43] mentions
outcome effect sizes. None of the identified RCTs report
any conflict of interest.
Pilot Studies
A total of 11 Pilot Studies were identified in our search
[44–54]. These studies were not included in the RCT group
because of the lack of a control group, randomization and/
or lack of detail of sessions and data. Nevertheless, these
pilot studies present significant results in terms of usability
and safety. The same analysis procedure used for RCT was
performed in these publications, and results are summa-
rized in Tables 5 and 6. A comprehensive list of the identi-
fied pilot studies is presented in Additional file 1.
Pilot studies are usually focused on proving the feasibility
of rehabilitation scenarios, in most cases regarding its safety
as well as ease of use in PD patients. Interestingly, most
studies reported improvement, and none reported deterior-
ation or safety risk as a consequence of the study. However,
due to low sample sizes and insufficient intervention dura-
tions, outcome changes were not statistically significant in
some cases. As it is the case for the RCTs, the evaluated
scenarios were a mixture of custom and commercial games,
with both of these providing similar results. Two of the
pilot studies [45, 50] mention the possibility of adapting
their modules to a minimally supervised home scenario, a
level of supervision that could be achieved, for example, by
relatives. The question of therapy adherence is mentioned,
but, as mentioned in the previous section, challenges re-
garding safety remain largely unaddressed.
We also discovered a very recent study offering the
first comparison between exergaming platforms specif-
ically for PD rehabilitation, specifically WBB and
Kinect [54]. Outcomes of this study suggest the WBB
may be more adequate for PD rehabilitation, at least in
the disease factors that can be evaluated through the
10MWT or TUG tests. This aspect is further men-
tioned in the discussion.
Discussion
The research activity in the area of exergames for the re-
habilitation of PD patients has improved impressively in
recent years. The previous systematic review by Barry et
al. [34] could only analyze seven studies and just one of
these qualified as RCT. By turn, in this systematic re-
view, we included 64 new studies, eight of which quali-
fied as a RCT. Our findings indicate that the putative
improvement in motor skills suggested before 2014 has
been confirmed by several independent studies including
both, RCTs and pilot studies. As a whole, from a total of
19 studies where exergame therapy was evaluated (both
RCTs and pilot studies), 17 demonstrated improvements
in the measured outcomes (8 out of 9 RCTs and 9 out of
Table 1 Input devices used in the analyzed publications. A pilot study [54] used both the Kinect and Wii sensors, and thus
represented in parenthesis in both columns. For the total count it is considered as Kinect
Kinect WBB WiiMote Custom Device/Other Total
Group 1: RCT 3 2 1 2 8
Group 2: Pilot 8(9) 2(3) 0 0 11
Group 3: Technical 24 3 1 2 30
Total 36 7 2 4 49
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11 pilot studies). Additionally, in 7 out of 9 RCTs the
intervention group provided better results than the
control group in motor outcomes. Finally, none of the
studies showed exergames were in any way worse than
traditional rehabilitation therapy. Additionally, exer-
games seem to improve cognitive skills (MOCA scores,
attention) in the aforementioned RCT study populations
(PD patients with MMSE scores > 24) as well.
From our analysis on recent RCTs, we can conclude
that the focus on using the WBB is switching towards
the Microsoft Kinect v2, which apparently provides simi-
lar results while being easier to use since patients do not
have to stand on an elevated platform. Recent research
shows how this sensor can provide relevant and accurate
gait parameters which can be potentially used to moni-
tor PD patients remotely during rehabilitation sessions.
However, RCTs using this platform remain scarce, while
positive WBB results are more numerous. Up to this
point, all RCTs include an MMSE score of 24 or higher
as an exclusion criterion. Thus, the effect of patients
with lower MMSE scores is yet to be determined. Con-
sidering recent studies show how exergaming does im-
prove cognitive capabilities in PD patients [35], it seems
necessary to extend these studies into PD-MCI as well
as initial PDD, and evaluate the feasibility of game-based
therapy on these patients as well.
An additional advantage presented by the Kinect over
the WBB or Wiimote seems to be that the risk of patient
not liking the input device used in the game is lower
[55]. How PD patients will react to speech control or an
improved version of a WBB is unknown, and the num-
ber of RCTs involving the Kinect is up to this point in-
sufficient. Future research should also consider new
sensors and methods, such as the Leap Motion finger
tracking sensor (see Table 7), which, as with the Kinect
sensor, does not require the user to wear it or carry any
weight. We believe this tendency will continue towards
other sensors and scenarios where the user can perform
natural movements, such as fine motor training with the
Leap Motion sensor.
Regarding outcome comparisons between exergaming
platforms. A recent pilot study [54] suggests the WBB
may be more optimal for Kinect in PD rehabilitation,
based on a comparison performed between these two plat-
forms. However, the meta-analysis of RCT outcomes
(Table 4) suggests otherwise: We found higher improve-
ments in the TUG test using WBB (1 WBB-Based RCT vs.
1 Kinect-based RCT) and better results with Kinect in
BBS (2 WBB-based RCTs vs 2 Kinect-based RCTs).
Considering technical papers, 19 [15–33] out of the 30
[15–33, 55–65] publications in this group focused to-
wards linking sensor parameters to disease severity indi-
cators. The use of these sensors for screening is
suggested [22, 33]. The limitations of the current gener-
ation of sensors, particularly in fine motorics, is also dis-
cussed [29]. In this case, a more dedicated sensor, such
as a data glove [56], or the Leap Motion sensor [65] may
be used. In addition, there is also clear interest in devel-
oping rehabilitation methods that may be performed in
an unsupervised home scenario [56, 59–63]. Patient
preferences regarding sensors are rarely discussed [55].
In parallel to these findings, 15 meta-analyses and sys-
tematic reviews were found [66–80]. These relate to a
wide array of topics, however, none of the studies we
found related to the specific topic of exergame-based re-
habilitation for PD specifically.
This study presents some limitations. Firstly, the lack
of standardized outcomes in this research area makes it
still difficult to determine which exergaming platform,
and method, works best for the specific needs of PD pa-
tients. The meta-analysis we could perform in this as-
pect was limited to the studies presented in Table 4 and,
Table 4 Comparison of RCT outcomes. Results are presented as mean (standard deviation) unless stated otherwise. Outcomes are
adimensional where no units are stated
Outcome: TUG (s) (Lower is
better)
Method Control -
Before
Intervention -
Before
Control -
After
Intervention -
After
Difference
control
Difference
Intervention
Liao et al. (2015) WBB - Wii Fit Plus 11.9 (2.7) 12.6 (4.1) 12.6 (3.6) 9.7 (2.1) 0.7 −2.9
Shih et al. (2016) Kinect - Custom
Game
9.5 (2.45) 10.05 (4.66) 8.71 (1.8) 9.18 (3.42) −0.79 −0.87
Song et al. (2017) Dance Mat –
Stepmania
9.51 (2.27) 9.57 (2.38) 9.02 (1.70) 9.72 (2.14) −0.49 0.15
Outcome: BBS (Higher is
better)
Pompeu et al. (2012) WBB - Wii Fit 51.9 (4.6) 52.9 (4.1) 53.1 (3.4) 54.4 (2.2) 1.2 1.5
Shih et al. (2016) Kinect - Custom
Game
50.9 (5.32) 50.4 (4.79) 53.2 (2.86) 53 (1.89) 2.3 2.6
Ribas et al. (2017) WBB - Custom Game 48.4 (2.63) 50.4 (2.79) 48.2 (2.89) 52.3 (2.26) −0.2 1.9
Tollar et al. (2018) [43] Kinect – Kinect
Adventures
26.3 (5.21) 23.6 (3.60) 24.9 (5.91) 32.4 (4.61) −1.4 8.8
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Table 6 Pilot Study Experiment Outcomes. BES = Balance Evaluation System, FIM = Functional Independence Measure, nMWT = n
Minutes Walking Test. S&E = Schwab and England Independence Scale. Results are presented as mean (standard deviation) unless
stated otherwise. Outcomes are adimensional where no units are stated
Author Outcome Baseline (Mean
(SD))
Post Intervention
(Mean (SD))
Main Results Main conclusion
Summa
et al.
(2013) [44]
Not described Not described Not described MWT and TUG improvement
in 3/5 users
Increase in movement
acceleration
Statistically significant
improvement of patients.
Palacios-
Navarro
et al. (2015) [45]
10MWT (s) • 12 (6) • 10 (5) Improvement in 10MWT test,
statistically significant
(p = 0.002)
Scenario is feasible, but long
term impact unknown.
Adaption to home scenario
proposed.
Summa et al.
(2015) [46]
TUG (s)
10MWT (s)
• 15 (12)
• 12 (12)
• 16 (15)
• 12 (13)
No significant changes on
standard outcomes.
Improvement in absolute
average acceleration
Scenario appears safe to use,
possible training-induced
reduction of bradykinesia.
Goncalves
et al.
(2014) [47]
UPDRS Motor
S&E Scale
FIM
• 28.5 (9.91)
• 79.3 (9.61)
• 114.3 (6.07)
• 15.8 (7.49)
• 90.0 (6.54)
• 121.3 (2.65)
Statistically significant
differences for all outcomes
(p < 0.001)
Increase in stride length and
gait speed
WBB gait motor training is
effective, even in a short
time period.
Pompeu et al.
(2015) [48]
Limit of Stability • 118.5 (28.0) • 163.7 (38.3) Improvement in limit of stability,
statistically significant
(p < 0.05)
Kinect training is safe and
promotes improvement in
postural control.
Pompeu
et al.
(2014) [49]
6MWT (m)
PDQ-39
BES
• 399.3 (72.4)
• 27.8 (8.3)
• 74.1 (12.7)
• 429.5 (90.6)
• 22.34 (1.9)
• 88.9 (14.8)
Effect sizes of 0.3 for 6MWT, 0.7
for PDQ-39
and 1.1 for BES.
Positive outcome, but the sample
size does not provide significant
results
Training with Kinect is safe
and feasible. Cardiopulmonary
endurance, balance, gait and
quality of life improves
Negrini
et al.
(2017) [50]
BBS
Tinetti balance
scale
Tinetti gait scale
10 sessions:
• 46.6 (5.8)
• 11.9 (3.2)
• 8.1 (2.9)
15 sessions:
• 40.1 (7.6)
• 12.2 (3.0)
• 9.0 (1.8)
10 sessions:
• 51.3 (7.2)
• 14.5 (3.2)
• 10.4 (1.8)
15 sessions:
• 46.3 (7.1)
• 13.6 (3.1)
• 10.1 (2.2)
All results statistically significant
within groups (p < 0.001).
10 sessions suffice to see results.
No significantly different results
with the 15 sessions group
Wii Fit is cost-efficient and
provides result, home scenario
may be viable.
Nuic et al.
(2018) [51]
UPDRS (Motor)
GABS Scale
FOG
Questionnaire
• 20.3 (7.8)
• Not reported
• 25.9 (5.4)
• Not Reported
• −38 points across
all users
• − 39 points across
all users
Statistically significant improvement
in FOG and GABS (p < 0.02),
differences in UPDRS scores not
significant (p = 0.13).
Game is feasible, well accepted
and shows potential for PD
rehabilitation.
Cikajlo
et al.
(2018) [52]
UPDRS (Motor)
Nine-Hole Test
Box and Blocks
Test
• 29.54 (10.33)
• 28.01 (6.59)
• 47.27 (10.68)
• 27.29 (10.38)
• 26.48 (7.30)
• 51.65 (11.26)
Statistically significant (p < 0.003)
improvement in UPDRS and Box
and Blocks, nonsignificant in
Nine-Hole Test (p = 0.089)
Telerehabilitation is possible with
training and remote supervision,
and achieving significant clinical
outcomes is possible-
Pradhan
(2018) [53]
Functional Reach
Test (cm)
6MWT (m)
Gait speed (m/s)
• 25.65(5.92)
• 502.11(36.54)
• 7.1(0.6)
• 33.71(2.84)
• 560.53(23.83)
• 6.97(0.90)
Statistically significant differences
(p < 0.05) on functional reach test
Certain improvements observed
Alves et al.
(2018) [54]
TUG (s)
10 MWT (s)
10 MWT (m)
• 10.44(2.16)/
11.68(5.22)
• 7.03(1.52)/
7.07(1.40)
• 1.47(0.31)/
1.44(0.21)
(Wii / Xbox)
• 9.77(1.5)/9.82 (3.41)
• 6.89(1.05)/
6.96(1.46)
• 1.47(0.23)/
1.48(0.27)
(Wii / Xbox)
Statistically significant improvement
in Wii outcomes (p > 0.049),
improvement in Kinect group
non-significant, no improvement in
control group.
Wii seems to perform better than
Kinect, since only the first group
shows statistically significant
improvement.
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although illustrative, requires significant extension be-
fore conclusions may be extracted. It is also early to
quantitatively determine the effect of exergame therapy
in PD-MCI and initial PDD patients, either in improve-
ment or slowdown of deterioration. Given that the ef-
fectiveness of exergames, at least in comparison with
traditional rehabilitation, seems to be comparable, it is
critical that future RCTs establish the use of a reduced
number of standard outcomes such as MDS-UPDRS,
BBS or TUG in order to start providing a more signifi-
cant insight into what scenarios and sensors are actually
more effective to train which difficulties of PD patients
in particular or motor afflictions in general. If authors
adhere to these principles, a repetition of this exercise
performed another 5 years from now may very well
provide critical insight in the development of game-
based PD-specific rehabilitation: Which sensors to use,
what game environments are optimal, and which are the
ideal difficulty adaptation curves based on UPDRS or
MMSE assessments.
Considering the effect of RCTs in cognition, perform-
ing a follow-up analysis is also essential to determine
long-term patient improvement in all outcomes, espe-
cially considering follow-up results seem to be good for
cognitive skills, but not for balance.
Although it is still difficult to determine, it seems there
is not a big difference between PD-specific games and
custom-developed games. For the patients included in
the analyzed clinical studies, that is, patients with MMSE
scores over 24, and although it is too early to make clear
conclusions, it seems that cognitive specific therapy and
commercial games have no significant difference in cog-
nitive outcomes, as seen on Table 3, although whether
this also applies to PD-MCI patients remains to be de-
termined. An RCT mentions the importance of task spe-
cificity in this case [41]. Other studies support the idea
that therapy should adapt to the patient’s skills, and this
would be possible with custom-developed adaptive exer-
games, but not with commercial ones.
Regarding sensors, it is clearly essential to further de-
termine what constitutes the right array of sensors to
ensure a pleasant experience while the most amount of
medically relevant information is captured in the back-
ground, adapting to the patients’ skills where possible.
Unfortunately, the number of studies in this regard is
very limited so far.
Another research field, parallel to the one presented in
this work, is the use of Virtual Reality in rehabilitation
in general and for PD in particular. A recent systematic
review [81] summarizes recent advances in this area in
the last years. Similarly to exergame-based rehabilitation,
limited evidence shows positive effects, but additional
studies are required to confirm the results.
Conclusions
In our opinion, the main conclusion of this study is that
exergame PD rehabilitation is indeed safe, feasible and
effective, and in some cases [37, 38, 40, 42] even more
effective than traditional rehabilitation and regular exer-
cise. Exergames also provide the possibility of a home
rehabilitation and remote monitoring scenario, which
are limitations of traditional rehabilitation methods.
There is contradictory evidence regarding which exer-
game platform performs better at this point.
Regarding future work, in addition to providing further,
high-quality clinical trials in order to confirm the hypoth-
eses so far presented, studies should focus on adapting
existing therapies to home scenarios, adding further data
collection procedures, such as monitoring hand tremors,
perhaps with a finger sensor [82]. Additional variables
such as dysphonia [83] and heart rate variability [84] may
also be of interest. Evaluating the feasibility of expanding
PD Exergame therapy to patients with PD-MCI and PDD,
and including new interaction techniques such as fine mo-
toric training and speech control are also points of inter-
est. Finally, programs should be tailored to patient
characteristics, both physical and cognitive.
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